News

Join our newsletter

Sign up to read about our latest portfolio updates, fund news and industry insights.

Thanks for subscribing to our newsletter
Oops! Something went wrong

Latest news

Portfolio
//
Aether Biomachines
//
April 12, 2022

Aether Biomachines and Allonnia Announce Partnership to Engineer Breakthrough Biological Solutions to Degrade PFAS and Other Harmful Environmental Toxins

Exclusive partnership to accelerate the removal of harmful toxins from the environment to help improve global human health

Portfolio
//
Coreshell Technologies
//
March 29, 2022

This startup’s novel tech promises to boost battery capacity for EVs – TechCrunch TechCrunch

Portfolio
//
YourChoice Therapeutics
//
March 23, 2022

Non-Hormonal Birth Control Pill for Men Could Start Human Trials Soon

The non-hormonal pill was 99% effective at preventing pregnancy in mice, new research found.

Portfolio
//
Coreshell Technologies
//
March 1, 2022

Coreshell Lands $12M To Unlock Battery Capacity for Electric Vehicle Brands

Coreshell’s breakthrough battery technology proven to extend capacity of lithium ion batteries by 30 or more percent - which would add over 80 miles in range for drivers. The first electric vehicle powered by Coreshell’s technology to be unveiled with Meyers Manx - the iconic original dune buggy.

Portfolio
//
Coreshell Technologies
//
February 26, 2022

WSJ: Why All Those EV-Battery ‘Breakthroughs’ You Hear About Aren’t Breaking Through

In the superheated market for batteries, promising lab developments often get overhyped by startups. ‘Liar, liar, battery supplier.’

Portfolio
//
Ayar Labs
//
February 24, 2022

Hewlett Packard Enterprise and Ayar Labs announce strategic collaboration and investment to develop next-generation data center architectures and networking with optical I/O | HPE Hewlett Packard Enterprise Hewlett Packard Enterprise HPE MyAccount My Bo�

HPE and Ayar Labs team up to design future silicon photonics solutions for HPE Slingshot interconnect and advanced disaggregated servers

Portfolio
//
GenEdit
//
February 1, 2022

Sarepta rushes for GenEdit's polymer nanoparticles in $57M gene editing delivery partnership | Fierce Biotech

Sarepta Therapeutics will pay GenEdit up to $57 million in the near-term for access to the

Portfolio
//
ImpriMed
//
January 28, 2022

ImpriMed CEO Sungwon Lim wins LifeSci Voice Leaders Award 2021

Congratulations to Sungwon Lim of ImpriMed, Inc. for winning the prestigious Life Sciences Voice Top Industry Leaders award. Thank you for driving the industry forward with your remarkable contributions and transformational work!